IDO1 and neoplasm: Results indicated that OXA could induce immunogenic death of tumor cells, while NLG919 inhibited activity of indoleamine 2,3-dioxygenase 1(IDO-1) in tumor cells, thereby overcoming the tumor immunosuppressive microenvironment.